Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01874938
What this trial is testing

LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Eli Lilly and Company 15
Early research (Phase 1)Study completedNCT01061749
What this trial is testing

Selumetinib and Cixutumumab in Treating Patients With Advanced Solid Malignancies

Who this might be right for
Adult Solid Neoplasm
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT06191978
What this trial is testing

A Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00490178
What this trial is testing

Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and Dyslipidemia

Who this might be right for
Diabetes Mellitus, Type 2Dyslipidemia
Solvay Pharmaceuticals 29
Large-scale testing (Phase 3)Study completedNCT03276936
What this trial is testing

Evaluate the Long-Term Safety of Topical Administration of FMX103 in the Treatment of Moderate to Severe Papulopustular Rosacea

Who this might be right for
Papulopustular Rosacea
Vyne Therapeutics Inc. 504
Early research (Phase 1)Looking for participantsNCT06326411
What this trial is testing

Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

Who this might be right for
OncologyMEK MutationRAF Gene Mutation+6 more
Nested Therapeutics, Inc 230
Testing effectiveness (Phase 2)Study completedNCT01958944
What this trial is testing

Evaluation of the Safety and Tolerability of Inhaled Nitric Oxide to Subjects With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Beyond Air Inc. 9
Post-approval studies (Phase 4)Study completedNCT00736034
What this trial is testing

The Efficacy of Phosphatidylserine-Omega3 in Elderly Subjects With Memory Impairment

Who this might be right for
Memory Impairment
Enzymotec 18
Testing effectiveness (Phase 2)Study completedNCT04660799
What this trial is testing

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT06535399
What this trial is testing

Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Hepatic ImpairmentHealthy Volunteers
Celgene 29
Testing effectiveness (Phase 2)Active Not RecruitingNCT06710132
What this trial is testing

Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor)

Who this might be right for
Solid TumorsGastric CancerNon-Small Cell Lung Cancer (NSCLC)+2 more
EMD Serono Research & Development Institute, Inc. 184
Early research (Phase 1)Ended earlyNCT06163898
What this trial is testing

Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Who this might be right for
Multiple Myeloma
Celgene 4
Large-scale testing (Phase 3)Study completedNCT00117598
What this trial is testing

Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)

Who this might be right for
Lymphoma
Pfizer 169
Large-scale testing (Phase 3)Enrolling By InvitationNCT07073014
What this trial is testing

Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
BioMarin Pharmaceutical 140
Early research (Phase 1)Study completedNCT04232514
What this trial is testing

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 28
Not applicableLooking for participantsNCT07827014
What this trial is testing

An Open-Label, Two-Arm Pilot Study of the Tolerability, Consumer Acceptability, and Exploratory Well-Being Outcomes of a Multi-Ingredient Protein Formula in Two Flavors in Healthy Adults

Who this might be right for
Healthy
Qualia Life Sciences 50
Early research (Phase 1)Study completedNCT01210404
What this trial is testing

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

Who this might be right for
Chronic Hepatitis C
Pfizer 12
Not applicableStudy completedNCT05937048
What this trial is testing

Coagulation Parameters With Albumin in Decompensated Cirrhosis (CoPA-D).

Who this might be right for
Decompensated Cirrhosis
Institute of Liver and Biliary Sciences, India 120
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Testing effectiveness (Phase 2)Ended earlyNCT06516926
What this trial is testing

SHR-4602 for Injection in Subjects With HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors

Who this might be right for
HER2-expressing or -Mutated Unresectable or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd. 11
Next Page